VivoSeq
Other

Apnea of Prematurity

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Apnea of Prematurity is an early-stage landscape with 0 programs across 1 company. The most active players are Nobelpharma.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

N

Nobelpharma

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

9

clinical trials

Completed7 · 78%
Active, not recruiting1 · 11%
Unknown status1 · 11%

Clinical Trials

Trial Activity

9 trials

Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.
Active, not recruiting·NNishtar Medical University·Phase 1·NCT06905496·114 enrolled
Caffeine for Apnea of Prematurity (CAP)
Completed·MMcMaster University·Phase 3·NCT00182312·2,000 enrolled
Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study
Completed·MMcMaster University·Phase 3·NCT01020357·201 enrolled
High Versus Low Dose of Caffeine for Apnea of Prematurity
Completed·MMansoura University Children Hospital·Phase 3·NCT02103777·120 enrolled
CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity
Completed·UUniversity of Manitoba·Phase 2/3·NCT01066728·87 enrolled
Clinical Study of Caffeine for Apnea of Prematurity
Completed·NNobelpharma·Phase 3·NCT01408173·24 enrolled
Prophylactic Versus Therapeutic Caffeine for Apnea of Prematurity
Completed·MMansoura University Children Hospital·N/A·NCT02677584·180 enrolled
PRETERM YENİDOĞANLARDA ANNE KOKUSUNUN APNE GELİŞİMİNE, FİZYOLOJİK PARAMETRELERE VE KİLO ALIMINA ETKİSİ
Completed·AAnkara Yildirim Beyazıt University·Preclinical·NCT07689669·60 enrolled
Caffeine for Preterm Infants With Apnea of Prematurity(AOP)
Unknown status·—·N/A·NCT03298347·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)